Impact of revised Task Force Criteria: distinguishing the athlete's heart from ARVC/D using cardiac magnetic resonance imaging

被引:38
作者
Luijkx, Tim [1 ]
Velthuis, Birgitta K. [1 ]
Prakken, Niek H. J. [1 ]
Cox, Moniek G. P. J. [2 ,3 ]
Bots, Michiel L. [4 ]
Mali, Willem P. T. Hm [1 ]
Hauer, Richard N. W. [2 ]
Cramer, Maarten J. [2 ]
机构
[1] Univ Med Ctr Utrecht, Dept Radiol, NL-3584 CX Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Cardiol, NL-3584 CX Utrecht, Netherlands
[3] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
关键词
ARVC/D; athletes; cardiac MRI; CMR; Task Force Criteria; RIGHT-VENTRICULAR CARDIOMYOPATHY; SURFACE-AREA; SUDDEN-DEATH; DIAGNOSIS; PARTICIPATION;
D O I
10.1177/1741826711414215
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiac magnetic resonance (CMR) evaluation of athletes for arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is complicated by overlapping features such as right ventricular (RV) volume increase. The revised ARVC/D diagnostic Task Force Criteria (TFC) incorporate cut-off values for RV ejection fraction (EF) and RV end-diastolic volume (EDV) on CMR. Design: To distinguish ARVC/D patients from athletes we compared CMR ventricular volumes, function, TFC cut-off values, and LV/RV ratios since athletes show proportionate, and ARVC/D patients disproportionate, changes in LV and RV. Methods: Quantitative CMR parameters of 33 ARVC/D patients (64% male, mean age 45.4 years, diagnosed by revised TFC), 66 healthy athletes and 66 healthy non-athletes (sex and age matched) were compared using revised TFC and new cut-off values representing LV/RV balance. Results and conclusions: Absolute values for ARVC/D patients/athletes/non-athletes were: in males, RV EDV 149/133/106 ml/m(2), ratio EDV LV/RV 0.70/0.91/0.93, RV EF 34/52/54%, LV EF 48/57/58%, ratio EF LV/RV 1.49/1.10/1.09; and in females, RV EDV 115/115/91 ml/m(2), ratio EDV LV/RV 0.86/0.94/0.97, RV EF 43/54/58%, LV EF 52/57/61%, ratio EF LV/RV 1.23/1.08/1.04 (p-values<0.05). Areas under the ROC-curve are 0.68 (RV EDV index), 0.84 (LV/RV EDV ratio) and 0.93 (RV EF), demonstrating significantly (p<0.001) better performance of RV EF and LV/RV EDV ratio. If a wall motion abnormality is present (observed in 30 ARVC/D patients and not in healthy subjects), RV EF can help distinguish ARVC/D from physiological cardiac adaptation in athletes on CMR whereas RV EDV index cannot. A good alternative in athletes is the LV/RV EDV ratio, representing normal proportionate adaptation of both ventricles.
引用
收藏
页码:885 / 891
页数:7
相关论文
共 30 条
[1]   Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria [J].
Basso, Cristina ;
Ronco, Federico ;
Marcus, Frank ;
Abudureheman, Aierken ;
Rizzo, Stefania ;
Frigo, Anna Chiara ;
Bauce, Barbara ;
Maddalena, Francesco ;
Nava, Andrea ;
Corrado, Domenico ;
Grigoletto, Francesco ;
Thiene, Gaetano .
EUROPEAN HEART JOURNAL, 2008, 29 (22) :2760-2771
[2]   Arrhythmogenic right ventricular cardiomyopathy [J].
Basso, Cristina ;
Corrado, Domenico ;
Marcus, Frank I. ;
Nava, Andrea ;
Thiene, Gaetano .
LANCET, 2009, 373 (9671) :1289-1300
[3]   Differences and similarities between arrhythmogenic right ventricular cardiomyopathy and athlete's heart adaptations [J].
Bauce, B. ;
Frigo, G. ;
Benini, G. ;
Michieli, P. ;
Basso, C. ;
Folino, A. F. ;
Rigato, I. ;
Mazzotti, E. ;
Daliento, L. ;
Thiene, G. ;
Nava, A. .
BRITISH JOURNAL OF SPORTS MEDICINE, 2010, 44 (02) :148-154
[4]   MR imaging of arrhythmogenic right ventricular cardiomyopathy: Morphologic findings and interobserver reliability [J].
Bluemke, DA ;
Krupinski, EA ;
Ovitt, T ;
Gear, K ;
Unger, E ;
Axel, L ;
Boxt, LM ;
Casolo, G ;
Ferrari, VA ;
Funaki, B ;
Globits, S ;
Higgins, CB ;
Julsrud, P ;
Lipton, M ;
Mawson, J ;
Nygren, A ;
Pennell, DJ ;
Stillman, A ;
White, RD ;
Wichter, T ;
Marcus, F .
CARDIOLOGY, 2003, 99 (03) :153-162
[5]   Misdiagnosis of Arrhythmogenic right ventricular Dysplasia/Cardiomyopathy [J].
Bomma, C ;
Rutberg, J ;
Tandri, H ;
Nasir, K ;
Roguin, A ;
Tichnell, C ;
Rodriguez, R ;
James, C ;
Kasper, E ;
Spevak, P ;
Bluemke, DA ;
Calkins, H .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2004, 15 (03) :300-306
[6]   Histologic findings in patients with clinical and instrumental diagnosis of sporadic arrhythmogenic right ventricular dysplasia [J].
Chimenti, C ;
Pieroni, M ;
Maseri, A ;
Frustaci, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :2305-2313
[7]   SUDDEN-DEATH IN YOUNG COMPETITIVE ATHLETES - CLINICOPATHOLOGICAL CORRELATIONS IN 22 CASES [J].
CORRADO, D ;
THIENE, G ;
NAVA, A ;
ROSSI, L ;
PENNELLI, N .
AMERICAN JOURNAL OF MEDICINE, 1990, 89 (05) :588-596
[8]   Pre-Participation Screening of Young Competitive Athletes for Prevention of Sudden Cardiac Death [J].
Corrado, Domenico ;
Basso, Cristina ;
Schiavon, Maurizio ;
Pelliccia, Antonio ;
Thiene, Gaetano .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (24) :1981-1989
[9]   Review: A gentle introduction to imputation of missing values [J].
Donders, A. Rogier T. ;
van der Heijden, Geert J. M. G. ;
Stijnen, Theo ;
Moons, Karel G. M. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2006, 59 (10) :1087-1091
[10]  
DUBOIS D, 1989, NUTRITION, V5, P303